Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study. Engstrom A, Wintzell V, Melbye M, Hviid A, et al. Diabetes Care 2023;46:351-360.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Engstrom A, Wintzell V, Melbye M, Hviid A, et al. Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study. Diabetes Care 2023;46:351-360.
PMID: 36508322